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 1 
Abstract 1 
The second messenger cyclic di-GMP is a near-ubiquitous signaling molecule that 2 
globally alters bacterial cell physiology to promote biofilm formation and community 3 
behavior. Much progress was made in recent years towards the identification and 4 
characterization of diguanylate cyclases and phosphodiersterases, enzymes involved 5 
in the synthesis and degradation of this signaling compound. In contrast, our 6 
knowledge of the nature and mechanistic details of c-di-GMP effector proteins lags 7 
behind, primarily because effective tools for their specific enrichment and rapid 8 
analysis are missing. In this report we demonstrate that a novel tri-functional c-di-9 
GMP-specific Capture Compound (cdG-CC) can be effectively used to identify and 10 
validate c-di-GMP binding proteins. The cdG-CC was able to specifically and 11 
efficiently pull-down bona fide c-di-GMP effector proteins. Furthermore, in 12 
combination with mass spectrometry (CCMS), this technology robustly identified a 13 
substantial fraction of the known c-di-GMP signaling components directly from cell 14 
extracts of different model organisms. Finally, we applied the CCMS technique to 15 
profile c-di-GMP binding proteins of Salmonella enterica serovar typhimurium. Our 16 
studies establish CCMS as a powerful and versatile tool to identify and analyze 17 
components of the cellular c-di-GMP pathway in a wide range of different organisms. 18 
19 
 2 
Cyclic di-GMP is a ubiquitous second messenger regulating growth and behavior of a 1 
wide range of gram-positive and gram-negative bacteria. In particular, c-di-GMP 2 
mediates the switch between single cell behavior and a community life style called 3 
biofilm, which is often associated with chronic infections of bacterial pathogens [1]. 4 
Major components of the regulatory network are the GGDEF and EAL domains that 5 
are widespread in bacteria and catalyze c-di-GMP synthesis and degradation, 6 
respectively [2]. The list of cellular processes controlled by c-di-GMP is ever-7 
increasing and includes the biosynthesis and secretion of surface adhesins and 8 
exopolysacharide (EPS) matrix components, different forms of cellular motility, long-9 
term survival and response to environmental stress, synthesis of secondary 10 
metabolites, regulated proteolysis and cell cycle progression, delivery of anti-11 
bacterial toxins, intracellular growth and the production of virulence factors in a 12 
range of animal and plant pathogens [2-4]. Despite of this wide variety of cellular 13 
functions that are modulated by c-di-GMP, the list of effector proteins has remained 14 
relatively sparse [2-4]. These include PilZ, small switch-like domains that undergo 15 
conformational change upon binding c-di-GMP. In addition, several members of the 16 
CRP/FNR and response regulator superfamilies of transcription regulators were 17 
shown to specifically bind c-di-GMP. Finally, a subgroup of GGDEF and EAL domains 18 
was recognized as c-di-GMP effector proteins adopting their novel functionality 19 
through the combined loss of catalytic activity and exploitation of their allosteric and 20 
active site binding pockets, respectively. While most known effector proteins were 21 
discovered through an “educated guess” approach that was based on their 22 
functional linkage to c-di-GMP mediated cellular processes, unbiased screening for 23 
novel effectors was hampered primarily by the lack of reliable and effective 24 
biochemical tools for their enrichment and isolation. Only one global recent study 25 
used a chemical proteomics approach to identify c-di-GMP binding proteins in P. 26 
aeruginosa [5]. Here we introduce a novel tri-functional capture molecule (cdG-CC) 27 
as an effective tool to identify specific c-di-GMP binding proteins directly from a 28 
complex mixture of macromolecules. The compound is based on a chemical scaffold 29 
harboring specificity, reactivity, and sorting properties (Fig. 1A) [6, 7]. 30 
To evaluate the potential of this compound for the specific enrichment and isolation 31 
of c-di-GMP binding proteins we first tested if the cdG-CC is able to pull down known 32 
 3 
c-di-GMP effector molecules directly from a solution with purified protein. We used 1 
the well-studied PilZ domain protein DgrA from C. crescentus [8]. The binding affinity 2 
of wild-type DgrA for c-di-GMP is in the low nanomolar range. In contrast, the 3 
binding mutant DgrAW75A has a Kd of 6.2 M and a DgrA mutant lacking 4 
coordinating Arg residues in the N-terminus (RR11AA) fails to bind c-di-GMP 5 
completely [8]. 0.5 µM purified wild-type and mutant hexahistidine-tagged proteins 6 
(Fig. 1B) were incubated with 10 µM cdG-CC, UV cross-linked for 4 min and pulled 7 
out with streptavidin coated magnetic beads. While DgrA was readily captured in the 8 
absence of any other ligand, the addition of a 100x excess of c-di-GMP abolished 9 
cdG-CC almost entirely (Fig. 1B). In contrast, an equal molar excess of GTP did not 10 
interfere with the cdG-CC pull down (Fig. 1B) arguing that cdG-CC binding to DgrA is 11 
highly specific. In agreement with this, the cdG-CC only inefficiently pulled-down the 12 
DgrAW75A mutant form and completely failed to bind the DgrARR11AA mutant (Fig. 13 
1B). These data are fully consistent with the binding affinities of the different DgrA 14 
forms for c-di-GMP and strongly argue that cdG-CC is able to specifically capture 15 
DgrA. Moreover, these experiments demonstrate that the cdG-CC is a valuable 16 
diagnostic tool to verify candidate c-di-GMP binding proteins.  17 
These results encouraged us to probe if the capture compound can be applied for 18 
the selective enrichment of c-di-GMP binding proteins from a more complex mixture 19 
of proteins. To test this, we captured soluble c-di-GMP binding proteins from cell 20 
extracts and probed immunoblots with PopA specific antibodies. PopA is a GGDEF 21 
effector protein that regulates cell cycle progression in C. crescentus in response to a 22 
cellular upshift of c-di-GMP during the G1-S phase transition [9, 10]. To bind c-di-23 
GMP PopA utilizes a conserved and well-defined binding pocket, which, in related 24 
catalytic GGDEF domains, is used as an allosteric I-site for product inhibition of the 25 
diguanylate cyclase (DGC) activity [11, 12]. As shown in Fig. 1C, PopA with a known 26 
Kd for c-di-GMP of 2.5 µM, was readily captured from C. crescentus cell lysates using 27 
3 µM cdG-CC and a total of 400 µg soluble protein. Pull down of PopA was inhibited 28 
in the presence of a large excess of c-di-GMP (1mM), while GTP did not interfere 29 
with cdG-CC binding (Fig. 1C), arguing that the cdG-CC interaction with PopA is highly 30 
specific. Likewise, no PopA was bound to the cdG-CC when using a strain expressing 31 
a PopA mutant that lacks the highly conserved Arg residue of the canonical RxxD I-32 
 4 
site binding motif (R357G) [9] (Fig. 1C). This indicated that the cdG-CC can enrich c-1 
di-GMP binding proteins directly from whole cell extracts in a highly specific manner 2 
and that this compound is suited for a global isolation procedure of c-di-GMP binding 3 
proteins. Therefore we combined capture experiments with the analysis of isolated 4 
proteins by LC-MS/MS (CCMS, [6, 7]). When applying 10, 5 or 2.5 M cdG-CC with 5 
400 g of soluble C. crescentus proteins, nine of eleven proteins predicted to contain 6 
either a PilZ, GGDEF or EAL domain (Table 1A and Supplementary Table S1A) were 7 
significantly enriched as compared to the competition control based on the spectral 8 
counts of the identified peptides. In addition to the analysis of soluble proteins we 9 
also aimed at evaluating the efficiency of CCMS for the enrichment of c-di-GMP 10 
binding proteins from membrane fractions. Although the numbers of spectral counts 11 
were lower as compared to proteins from the soluble fraction, three of the five 12 
integral membrane proteins predicted to bind c-di-GMP were identified when 400 13 
g DDM solubilized membrane proteins and 10 M cdG-CC were used for CCMS 14 
(Table 1A and Supplementary Table S1A). Only four of the known components of the 15 
C. crescentus c-di-GMP network were not identified by CCMS. Two of these are 16 
integral membrane proteins with several predicted membrane spanning domains in 17 
their N-terminal regions (CC0740, CC0896). It is possible that they were not 18 
solubilzed by the detergent used or not detected by LC-MS/MS. Another possibility is 19 
that they are not expressed, as it might be the case for CC3094 and CC3148. 20 
To expand these studies to a different organism, we also tried to isolate known c-di-21 
GMP binding proteins from P. aeruginosa PA01. With over 40 GGDEF and EAL 22 
domain and eight PilZ domain proteins annotated, the complexity of the c-di-GMP 23 
signaling network in this organism is much higher than in C. crescentus. Using 10 M, 24 
7.5 µM, 5 µM, 2.5 µM and 1.25 µM cdG-CC and 350 µg of soluble protein extract, 25 
several of these proteins were unambiguously identified by CCMS (Table 1B and 26 
Supplementary Table S1B). This includes four PilZ domain proteins, four GGDEF and 27 
two composite GGDEF-EAL domain proteins. The fraction of the P. aeruginosa 28 
proteins predicted to bind c-di-GMP that were isolated by CCMS is substantially 29 
lower (10 of 28 predicted soluble proteins) as compared to C. crescentus but is 30 
comparable to a recent study using sepharose-coupled c-di-GMP [5]. The 31 
 5 
discrepancy between C. crescentus and P. aeruginosa might be related to the fact 1 
that many of these proteins are engaged in the transition between a motile, 2 
planktonic and a sessile, surface attached life-style. Since C. crescentus has 3 
integrated this developmental transition into its reproductive cycle [13], most of the 4 
components of the c-di-GMP network orchestrating this switch, need to be 5 
expressed in cells growing in liquid cultures [10]. In contrast, P. aeruginosa adapts its 6 
expression program upon surface colonization in response to environmental cues 7 
[14]. It is thus possible that several components of the P. aeruginosa core machinery 8 
required to adapt to surface communities are simply not expressed in logarithmically 9 
growing cultures in liquid media. To test this, it would be interesting to repeat theses 10 
experiments with cell extracts harvested from surface grown P. aeruginosa 11 
communities.  12 
To evaluate whether cdG-CC based CCMS can be used to profile an entire cellular 13 
network of c-di-GMP binding proteins we used S. typhimurium. This organism was 14 
chosen to perform an unbiased CCMS experiment because its c-di-GMP network 15 
appears to be of lower complexity as compared to other bacterial species [15]. In 16 
contrast to the CCMS experiments with C. crescentus and P. aeruginosa, in which 17 
spectral counts were extracted for known c-di-GMP binders, we tested whether 18 
CCMS is capable to enrich for c-di-GMP binding proteins upon MS1 label-free 19 
quantification. CCMS experiments were performed in triplicates with 350 g soluble 20 
whole cell proteins using 7.5 M cdG-CC and competition controls with an excess of 21 
c-di-GMP (1 mM) (Supplementary Table S2A). Following mass spectrometry analysis 22 
and label-free quantification (Supplementary Table S2B) significant differences in 23 
protein enrichment between cdG-CC experiments and control samples with 24 
competing c-di-GMP were visualized in a volcanoplot. The graph shows a significant 25 
enrichment (>2 fold) of 36 proteins as compared to the control with a q-value <0.05 26 
(Supplementary Table S2C and Fig. 2). Among the enriched proteins is the PilZ 27 
domain protein YcgR (Fig. 2) [16]. Many of the identified components that were not 28 
previously associated with the c-di-GMP network were metabolic proteins and 29 
proteins involved in fatty acid and LPS biosynthesis (Fig. 2). Such proteins are of 30 
great interest in the light of switching between a virulent planktonic and a surface 31 
attached persistent lifestyle. However, since none of these proteins show homology 32 
 6 
to known c-di-GMP binding proteins, they first need to be validated to specifically 1 
bind c-di-GMP and be part of the c-di-GMP signaling network. In addition also some 2 
background proteins are enriched. They are mostly binders of other nucleotides or 3 
proteins that are known to be highly abundant, such as five tRNA-related proteins or 4 
the chaperone GroEL (Supplementary Table S2C). 5 
6 
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Figure legends: 1 
Fig. 1 - The cdG-CC can specifically pull down bona fide c-di-GMP binding proteins 2 
from purified and from crude cell extracts. A) Chemical structure of cdG-CC. C-di-3 
GMP provides the selectivity for capturing proteins. The photo-reactivity group 4 
allows irreversible nitren formation between the compound and the captured 5 
protein. Biotin as sorting function allows the isolation of the compound by binding to 6 
streptavidin coated magnetic beads.  B) Immunoblot of purified and captured DgrA 7 
(wt), DgrA W75A and DgrA RR11AA. In all capture experiments 10 M cdG-CC was 8 
present, in competition experiments the proteins were preincubated with a 100 x 9 
excess of c-di-GMP (cdG) or GTP. All proteins were His-tagged and detected using 10 
anti-His antibodies. C) Immunoblot of PopA. PopA (wt) or the PopA I-site mutant 11 
R357G was expressed in NA1000popA (lanes marked with ‘proteins’; note that this 12 
I-site mutant is less abundant in the cell). PopA was captured in the presence of 3 13 
M cdG-CC. Addition of 1 mM c-di-GMP but not 1 mM GTP prevented the binding to 14 
the cdG-CC. In contrast the PopA I-site mutant could not be captured at all. PopA 15 
was detected using anti-PopA antibodies. 16 
 17 
Fig. 2 - Volcanoplot based visualization of proteins significantly enriched by CCMS of 18 
S. typhimurium. Following capturing, LC-MS/MS analysis and label-free quantification, 19 
log2-intensity ratio of all detected peptide features between capturing and 20 
competition experiment were calculated and plotted versus values derived from 21 
significance analysis. Proteins within the significance thresholds for q-values <0.05 22 
and intensity ratios >2-fold are indicated in a box. Experiments in triplicate were 23 
performed in the presence of 7.5 M cdG-CC and with 1 mM c-di-GMP added to the 24 
competition reactions. 25 
26 
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Table 1 - Identified known c-di-GMP binding proteins. 1 
A) C. cresentus 2 
Protein Name ID Domain architecture CCMS experiment/CCMS competition1) 
      No spectral counts of identified peptides 
Soluble fraction:     
Experiment 2)     1 2 3 
PopA CCNA_01918 GGDEF 20/1 25/3 15/5 
PleD CCNA_02546 Rec-Rec-GGDEF 18/0 21/2 13/5 
DgcA CCNA_03394 GGDEF 5/0 3/0 1/0 
DgcB CCNA_01926 GGDEF 12/1 16/3 10/2 
CC0655 CCNA_00692 PAC-GGDEF-EAL 8/0 18/0 19/0 
CC1086 CCNA_01140 PAS-EAL 8/0 5/0 4/0 
PdeA CCNA_03507 GGDEF-EAL 3/0 5/0 6/0 
DgrA CCNA_01671 PilZ 5/0 6/3 6/1 
DgrB CCNA_03268 PilZ   2/0   
      
Membrane fraction:     
Experiment3)           
TipF CCNA_00747 EAL 3/0 23/13   
PdeB CCNA_00089 3x(MHYT)-PAS-GGDEF-EAL 3/0 6/0   
CC0857 CCNA_00900 CHASE4-GGDEF-EAL   2/0   
 3 
1) All competition experiments were performed in the presence of 1 mM c-di-GMP. 4 
2) 3 independent experiments are indicated using 10, 5 or 2.5 M cdG-CC 5 
respectively. 6 
3) 2 independent experiments are indicated using 10 M cdG-CC. 7 
8 
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B) Soluble proteins of P. aeruginosa 1 
                
Protein Name ID Domain architecture CCMS experiment/CCMS competition1) 
      No of spectral counts of identified peptides 
Experiment No4)     1 2 3 4 5 
FimX PA4959 PAS-GDSIF-EVL 9/0 10/0 9/0 8/0 7/0 
  PA3353 PilZ 5/0 6/0 6/0 10/0 7/0 
WspR PA3702 Rec-GGEEF 2/0 2/0 2/0     
  PA0012 PilZ   2/0 1/0    
  PA0169 GGEEF 2/0 2/0 2/0     
  PA4843 Rec-Rec-GGEEF   2/0 2/0 5/0 3/0 
  PA2989 PilZ 1/0 1/0 1/0 1/0 1/0 
  PA0290 PAS-Rec-GGEEF 1/0     2/0 2/0 
  PA2567 GAF-SPTRF-EAL   1/0 1/0   1/0 
  PA4608 PilZ 1/0 2/0 2/0 2/0 1/0 
 2 
4) Eperiment 1 was performed with 10 µM cdG-CC, experiment 2 with 7.5 µM cdG-CC, 3 
experiment 3 with 2.5 µM cdG-CC, experiment 4 with 2.5 µM cdG-CC and experiment 5 4 
with 1.25 µM cdG-CC. 5 
 6 
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